Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOR007 Ointment in Psoriasis Plaque Test
NCT03004339Phase 1Completed
- Sponsor
- DFB Soria
- Start
- Aug 2016
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of SOR007 Ointment Placebo in plaque psoriasis (6 arms), sponsored by DFB Soria. Primary endpoint: Change in the thickness of the echolucent band at 12 days. Started Aug 2016; status: completed.
02
Drugs
SOR007 Ointment Placebo
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03004339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004339.